Biblio Discovery — Demo Discovery Service

4 hasil untuk "Simonson, Mathilde"

Menampilkan 1–4 · 0,52 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Protein, amino acids and obesity treatment

    Simonson, Mathilde; Boirie, Yves; Guillet, Christelle

    Rev Endocr Metab Disord · 2020 · Inggris · PubMed Central

    Dietary proteins have been used for years to treat obesity. Body weight loss is beneficial when it concerns fat mass, but loss of fat free mass – especially muscle might be detrimental. This occurs because protein breakdown predominates over synthesis, thus administering anabolic dietary compounds…

  2. Artikel Jurnal Teks lengkap

    An overview of basic pathophysiological interactions between gut bacteria and their host

    Simonson, Mathilde; Simonson, Thomas; Nobécourt, Estelle

    Front Nutr · 2025 · Inggris · PubMed Central

    Sometimes referred to as a “forgotten organ,” the gut microbiome (GMB) of humans includes hundreds of commensal bacterial species, which carry several million genes and complement our physiology. Commensal bacteria break down indigestible dietary fiber and provide essential metabolites. These often…

  3. Artikel Jurnal Teks lengkap

    Prediabetes in a French overseas territory: Clinical Characteristics, Risk Factors, and Implications for type 2 diabetes prevention

    Bun, René; Tounkara, Babacar; Leruste, Sébastien dkk.

    Prev Med Rep · 2024 · Inggris · PubMed Central

    BACKGROUND: People with prediabetes are at high risk of developing type 2 diabetes (T2D). This study evaluates clinical, sociodemographic characteristics, and Finnish Diabetes Risk Score (FINDRISC) of individuals with prediabetes recruited in primary care by their general practitioner (GP) for…

  4. Artikel Jurnal Teks lengkap

    Outcome Prediction at Patient Level Derived from Pre-Treatment 18F-FDG PET Due to Machine Learning in Metastatic Melanoma Treated with Anti-PD1 Treatment

    Flaus, Anthime; Habouzit, Vincent; de Leiris, Nicolas dkk.

    Diagnostics (Basel) · 2022 · Inggris · PubMed Central

    (1) Background: As outcome of patients with metastatic melanoma treated with anti-PD1 immunotherapy can vary in success, predictors are needed. We aimed to predict at the patients’ levels, overall survival (OS) and progression-free survival (PFS) after one year of immunotherapy, based on their…